aTYR PHARMA (ATYR) Short term Debt (2014 - 2020)
aTYR PHARMA's (ATYR) quarterly Short term Debt came in at $3.1 million in Q3 2020, down 60.98% YoY from $7.8 million in Q4 2019, and down 38.48% on a QoQ basis from $5.0 million in Q2 2020.
aTYR PHARMA (ATYR) Short term Debt (2014 - 2020) Analysis & Trends
aTYR PHARMA (ATYR) has 7 years of Short term Debt data on file, last reported at $3.1 million in Q3 2020.
- Quarterly Short term Debt fell 60.98% year-over-year to $3.1 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $3.1 million (down 60.98% YoY) and the FY2019 annual result came in at $8.7 million, up 12.49% from the prior year.
- Short term Debt fell to $3.1 million in Q3 2020, from $5.0 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $8.7 million in Q4 2019 to a low of $339000.0 in Q4 2016.
- A 5-year average of $5.2 million and a median of $5.0 million in 2017 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2016 — Short term Debt plunged 89.93% — and 2017, when it jumped 1378.47%.
- Tracing ATYR's Short term Debt over 5 years: stood at $339000.0 in 2016, then jumped by 1378.47% to $5.0 million in 2017, then soared by 54.97% to $7.8 million in 2018, then gained by 12.49% to $8.7 million in 2019, then tumbled by 64.97% to $3.1 million in 2020.
- The last three Short term Debt figures came in at $3.1 million (Q3 2020), $5.0 million (Q2 2020), and $6.9 million (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | aTYR PHARMA | 49.54 Mn | -7.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 3.06 Mn |
| Jun 30, 2020 | 4.98 Mn |
| Mar 31, 2020 | 6.87 Mn |
| Dec 31, 2019 | 8.74 Mn |
| Sep 30, 2019 | 7.84 Mn |
| Jun 30, 2019 | 7.82 Mn |
| Mar 31, 2019 | 7.79 Mn |
| Dec 31, 2018 | 7.77 Mn |
| Sep 30, 2018 | 7.74 Mn |
| Jun 30, 2018 | 7.72 Mn |
| Mar 31, 2018 | 7.03 Mn |
| Dec 31, 2017 | 5.01 Mn |
| Sep 30, 2017 | 2.27 Mn |
| Jun 30, 2017 | 2.79 Mn |
| Mar 31, 2017 | 1.09 Mn |
| Dec 31, 2016 | 339,000.00 |
| Sep 30, 2016 | 2.64 Mn |
| Jun 30, 2016 | 3.49 Mn |
| Mar 31, 2016 | 3.43 Mn |
| Dec 31, 2015 | 3.37 Mn |